1222580

Resilience Biotechnologies, Inc. — FEI 3007503037

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 10, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Mississauga (Canada)

Citations

IDCFRDescription
145121 CFR 211.113(b)Procedures for sterile drug products
202721 CFR 211.192Investigations of discrepancies, failures